{"id":"ambroxol-bih1526","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL153479","moleculeType":"Small molecule","molecularWeight":"378.11"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Ambroxol BIH1526 is a derivative of ambroxol, a compound that has been shown to increase the concentration of glutathione in the airways. Glutathione is an antioxidant that helps to protect the airways from damage and inflammation, and it also helps to break down and clear mucus. By increasing the concentration of glutathione, ambroxol BIH1526 helps to make it easier to breathe and to clear mucus from the airways.","oneSentence":"Ambroxol BIH1526 is a mucolytic agent that works by increasing the concentration of glutathione in the airways, which helps to break down and clear mucus.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:01:07.245Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic obstructive pulmonary disease (COPD)"}]},"trialDetails":[{"nctId":"NCT03583658","phase":"PHASE3","title":"Efficacy and Safety Study of New Ambroxol Hardboiled Lozenges in Acute Pharyngitis","status":"COMPLETED","sponsor":"Sanofi","startDate":"2018-06-30","conditions":"Pharyngitis","enrollment":390}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"ambroxol BIH1526","genericName":"ambroxol BIH1526","companyName":"Sanofi","companyId":"sanofi","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ambroxol BIH1526 is a mucolytic agent that works by increasing the concentration of glutathione in the airways, which helps to break down and clear mucus. Used for Chronic obstructive pulmonary disease (COPD).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}